POINT Biopharma Global In... (PNT)

AI Score

Unlock

12.50

0.02 (0.16%)

At close: Dec 26, 2023, 9:00 PM

POINT Biopharma Global Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Apr 30, 2020
Cash & Equivalents	21.61M	57.29M	111.14M	286.43M	125.78M	78.11M	227.39M	238.82M	252.83M	273.74M	699.53K	10.55M	1.14M	n/a	25K
Short-Term Investments	317.56M	365.93M	318.89M	238.78M	165.74M	121.32M	n/a	n/a	n/a	n/a	135.71M	135.71B	n/a	n/a	n/a
Long-Term Investments	59.79M	11.57M	89.17M	16.12M	n/a	4.9M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	5.12M	5.03M	-123.94M	-47.5M	-29.46M	n/a	n/a	n/a	n/a	n/a	135.71M	n/a	135.7M	n/a	90.31K
Receivables	9.39M	3.73M	159.04K	60.22K	169.61K	143.1K	90.03K	72.67K	48.62K	31.49K	n/a	58.98K	n/a	n/a	n/a
Inventory	4.2M	5.2M	4.2M	5.34M	4.32M	5.14M	4.87M	4.85M	6.25M	7.98M	n/a	1.76M	n/a	n/a	n/a
Other Current Assets	492.79K	217.32K	189.28K	215.2K	220.75K	191K	271.91K	105.45K	173.06K	64.6K	88.82K	27.63K	123.82K	n/a	n/a
Total Current Assets	353.25M	432.38M	434.58M	530.82M	296.23M	204.91M	232.61M	243.85M	259.29M	281.81M	788.35K	12.4M	1.27M	n/a	25K
Property-Plant & Equipment	59.55M	48.8M	34.77M	31.38M	29.46M	24.44M	20.37M	19.41M	17.9M	15.65M	n/a	9.8M	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	124.46M	65.4M	123.94M	47.5M	29.46M	29.34M	20.37M	19.41M	17.9M	15.65M	135.71M	9.8M	135.7M	n/a	90.31K
Total Assets	477.7M	497.77M	558.52M	578.32M	325.69M	234.24M	252.98M	263.26M	277.2M	297.46M	136.5M	22.19M	136.97M	n/a	115.31K
Account Payables	8.89M	13.9M	15.92M	7.68M	3.2M	8.07M	6.12M	1.74M	3.22M	5.02M	352.74K	3.6M	5.19K	n/a	n/a
Deferred Revenue	12.59M	15.9M	16.52M	23.24M	n/a	n/a	n/a	n/a	n/a	189.37K	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.93M	1.26M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.56M	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	15.27M	10.1M	45.41M	48.82M	13.41M	10.73M	7.52M	6.24M	4.88M	3.15M	5.5M	1.57M	46.55K	n/a	102.14K
Total Current Liabilities	38.67M	41.16M	77.85M	79.74M	16.61M	18.8M	13.64M	7.98M	8.09M	11.91M	5.86M	5.16M	51.73K	n/a	102.14K
Long-Term Debt	8.74M	4.52M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.55M	n/a	n/a	n/a
Other Long-Term Liabilities	2.39M	1.45M	1.45M	1.45M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.75M	n/a	n/a
Total Long-Term Liabilities	14.85M	9.17M	8.9M	11.63M	3.2M	65.59K	65.59K	65.59K	62.72K	62.72K	4.75M	3.55M	4.75M	n/a	n/a
Total Liabilities	53.51M	50.32M	86.74M	91.37M	16.61M	18.86M	13.71M	8.05M	8.16M	11.97M	5.86M	8.71M	4.8M	n/a	102.14K
Total Debt	10.66M	5.77M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.56M	n/a	3.55M	n/a	n/a	n/a
Common Stock	10.58K	10.58K	10.57K	10.56K	10.4K	9.01K	9.01K	9.01K	9.01K	9.01K	125.64M	5.46K	127.17M	n/a	288.00
Retained Earnings	-27.71M	-2.93M	22.48M	39.01M	-124.26M	-100.25M	-75.67M	-59.28M	-45.09M	-27.97M	-1.71M	-13.38M	-184.71K	n/a	-11.84K
Comprehensive Income	-1.43M	-1.07M	-255.56K	-456.85K	-608.7K	-342.38K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	424.19M	447.45M	471.78M	486.95M	309.08M	215.38M	239.27M	255.21M	269.04M	285.49M	130.64M	13.48M	132.17M	n/a	13.16K
Total Investments	377.35M	377.5M	408.06B	238.78M	165.74M	126.22M	n/a	n/a	n/a	n/a	135.71M	135.71B	n/a	n/a	n/a